Literature DB >> 21809363

Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling.

Jin-fang Zhang1, Ming-liang He, Wei-ming Fu, Hua Wang, Lian-zhou Chen, Xiao Zhu, Ying Chen, Dan Xie, Paul Lai, Gong Chen, Gang Lu, Marie C M Lin, Hsiang-fu Kung.   

Abstract

UNLABELLED: MiR-637 (microRNA-637) is a primate-specific miRNA belonging to the small noncoding RNA family, which represses gene regulation at the post-transcriptional expression level. Although it was discovered approximately 5 years ago, its biomedical significance and regulatory mechanism remain obscure. Our preliminary data showed that miR-637 was significantly suppressed in four HCC cell lines and, also, in most of the hepatocellular carcinoma (HCC) specimens, thereby suggesting that miR-637 would be a tumor suppressor in HCC. Simultaneously, the enforced overexpression of miR-637 dramatically inhibited cell growth and induced the apoptosis of HCC cells. The transcription factor, signal transducer and activator of transcription 3 (Stat3), is constitutively activated in multiple tumors, and aberrant Stat3 activation is linked to the promotion of growth and desensitization of apoptosis. Our study showed that Stat3 tyrosine 705 phosphorylation and several Stat3-regulated antiapoptotic genes were down-regulated in miR-637 mimics-transfected and Lv-miR637-infected HCC cells. In addition, miR-637 overexpression negatively regulated Stat3 phosphorylation by suppressing autocrine leukemia inhibitory factor (LIF) expression and exogenous LIF-triggered Stat3 activation and rescued cell growth in these cells. A nude mice model also demonstrated the above-described results, which were obtained from the cell model. Furthermore, we found that LIF was highly expressed in a large proportion of HCC specimens, and its expression was inversely associated with miR-637 expression.
CONCLUSION: Our data indicate that miR-637 acted as a tumor suppressor in HCC, and the suppressive effect was mediated, at least in part, by the disruption of Stat3 activation.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21809363     DOI: 10.1002/hep.24595

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  64 in total

1.  Novel Long Non-coding RNA lncAMPC Promotes Metastasis and Immunosuppression in Prostate Cancer by Stimulating LIF/LIFR Expression.

Authors:  Wei Zhang; Xiaolei Shi; Rui Chen; Yasheng Zhu; Shihong Peng; Yifan Chang; Xinwen Nian; Guang'an Xiao; Ziyu Fang; Yaoming Li; Zhexu Cao; Lin Zhao; Guang Liu; Yinghao Sun; Shancheng Ren
Journal:  Mol Ther       Date:  2020-06-15       Impact factor: 11.454

2.  MicroRNA-125b-5p mediates post-transcriptional regulation of hepatitis B virus replication via the LIN28B/let-7 axis.

Authors:  Wanyu Deng; Xiaoyong Zhang; Zhiyong Ma; Yong Lin; Mengji Lu
Journal:  RNA Biol       Date:  2017-03-07       Impact factor: 4.652

3.  A novel tumor suppressor miRNA miR-520e contributes to suppression of hepatoma.

Authors:  Bo-an Li
Journal:  Acta Pharmacol Sin       Date:  2012-01       Impact factor: 6.150

Review 4.  The role of microRNAs in hepatocarcinogenesis: current knowledge and future prospects.

Authors:  Motoyuki Otsuka; Takahiro Kishikawa; Takeshi Yoshikawa; Motoko Ohno; Akemi Takata; Chikako Shibata; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2013-11-21       Impact factor: 7.527

5.  A primate-specific microRNA enters the lung cancer landscape.

Authors:  Ana I Robles; Curtis C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

6.  Molecular mechanisms underlying application of serum procalcitonin and stool miR-637 in prognosis of acute ischemic stroke.

Authors:  You-Mei Li; Xue-Yuan Liu
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

7.  16p11.2 microdeletion imparts transcriptional alterations in human iPSC-derived models of early neural development.

Authors:  Julien G Roth; Kristin L Muench; Aditya Asokan; Victoria M Mallett; Hui Gai; Yogendra Verma; Stephen Weber; Carol Charlton; Jonas L Fowler; Kyle M Loh; Ricardo E Dolmetsch; Theo D Palmer
Journal:  Elife       Date:  2020-11-10       Impact factor: 8.140

8.  Long non-coding RNA FAL1 functions as a ceRNA to antagonize the effect of miR-637 on the down-regulation of AKT1 in Hirschsprung's disease.

Authors:  Yang Li; Lingling Zhou; Changgui Lu; Qiyang Shen; Yang Su; Zhengke Zhi; Feng Wu; Hua Zhang; Zechao Wen; Guanglin Chen; Hongxing Li; Yankai Xia; Weibing Tang
Journal:  Cell Prolif       Date:  2018-07-30       Impact factor: 6.831

9.  Posttranscriptional Regulation of the Inflammatory Marker C-Reactive Protein by the RNA-Binding Protein HuR and MicroRNA 637.

Authors:  Yoonseo Kim; Nicole Noren Hooten; Douglas F Dluzen; Jennifer L Martindale; Myriam Gorospe; Michele K Evans
Journal:  Mol Cell Biol       Date:  2015-10-05       Impact factor: 4.272

10.  Integrated Interaction Network of MicroRNA Target Genes in Keloid Scarring.

Authors:  Lechun Lyu; Yu Zhao; Hongquan Lu; Zijie Liu; Jiazhi Guo; Di Lu; Xiang Li
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.